2021
DOI: 10.1111/vco.12695
|View full text |Cite
|
Sign up to set email alerts
|

A newly established canine NK‐type cell line and its cytotoxic properties

Abstract: We established a canine natural killer (NK)‐type cell line called CNK‐89 derived from a dog with NK cell neoplasia. Immunophenotyping analysis showed positive staining for CD5, CD8, CD45, CD56, CD79a and NKp46, while negative for CD3, CD4, CD14, CD20, CD21, CD34, Thy1, IgG, IgM and MHCII. Polymerase chain reaction analysis revealed the presence of CD56, NKG2D, NKp30, NKp44, NKp46 and perforin, but the absence of CD16, Ly49 and granzyme B mRNA. Treating CNK‐89 cells with IL‐2 did not change the expression of ac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 9 publications
(14 citation statements)
references
References 31 publications
0
10
0
Order By: Relevance
“…A structural isomer of lactone 3, namely 2 -methoxy derivative 2, showed lower cytotoxic potency, as illustrated in Table 1 by IC 50 values for each derivative. Both compounds were more effective towards CLBL-1 and CLB70 cell lines (representing B-cell lymphoma and chronic type B leukemia, respectively) [21,22] than towards the rarer and more difficultto-treat types of hematopoietic cancer in dogs-acute leukemia of not clearly defined phenotype (B/T) [22,23], or NK cell lymphoma [24]. The remaining tests confirmed that the difference between these isomers concerns only the strength of their action and not the way in which they kill cancer cells.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…A structural isomer of lactone 3, namely 2 -methoxy derivative 2, showed lower cytotoxic potency, as illustrated in Table 1 by IC 50 values for each derivative. Both compounds were more effective towards CLBL-1 and CLB70 cell lines (representing B-cell lymphoma and chronic type B leukemia, respectively) [21,22] than towards the rarer and more difficultto-treat types of hematopoietic cancer in dogs-acute leukemia of not clearly defined phenotype (B/T) [22,23], or NK cell lymphoma [24]. The remaining tests confirmed that the difference between these isomers concerns only the strength of their action and not the way in which they kill cancer cells.…”
Section: Discussionmentioning
confidence: 98%
“…The study involved a panel of canine cancer cell lines: CLBL-1 (B-cell lymphoma), GL-1 (B/T-cell leukemia), CLB70 (B-cell chronic lymphocytic leukemia) and CNK-89 (NK-cell lymphoma), and a normal canine cell line (MDCK). CLBL-1 was obtained from Barbara C. Ruetgen from the Institute of Immunology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria [22]; GL-1 from Yasuhito Fujino and Hajime Tsujimoto of the University of Tokyo, Department of Veterinary Internal Medicine [23]; while CLB70 [21] and CNK-89 [24] were established in our laboratory. The MDCK cell line was purchased from Sigma Aldrich (Steinheim, Germany).…”
Section: Cell Lines and Cell Culturementioning
confidence: 99%
“…The increasing availability of a wide panel of various canine cancer cell lines hugely facilitates such studies. [66][67][68][69] Due to significance of DDR disorders in the cancer development in dogs, this review discusses the key components of the DDR, presents their physiological role and the abnormalities associated with these proteins found in canine cancers. We consider findings on the potential causes of genetic instability in canine cancers and indicate potential new research directions.…”
Section: Dna Damage Response In Canine Cancersmentioning
confidence: 99%
“…The increasing availability of a wide panel of various canine cancer cell lines hugely facilitates such studies. 66 , 67 , 68 , 69 …”
Section: Introductionmentioning
confidence: 99%
“…GL-1 [60] was provided by Yasuhito Fujino and Hajime Tsujimoto from the University of Tokyo, Department of Veterinary Internal Medicine. CLB70 [61] and CNK-89 [62] were established in our laboratory.…”
Section: Cell Lines and Cell Culturementioning
confidence: 99%